Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies

Diabetologia
DECODE Insulin Study Group

Abstract

We examined the association between plasma insulin and cardiovascular mortality in non-diabetic European men and women based on data from eleven prospective studies. The study population comprised 6156 men and 5351 women aged 30-89 years. Baseline measurements included oral glucose tolerance test, fasting and 2-h plasma insulin, and conventional risk factors. Cox models were used to calculate hazard ratios (HRs) and their 95% confidence intervals, and overall HRs were assessed by meta-analyses. During the 8.8-year follow-up, 362 men and 70 women died from cardiovascular disease. The age- and smoking-adjusted overall HR of cardiovascular mortality for the highest vs the lower quartiles of fasting insulin was 1.58 (95% CI: 1.26-1.97) in men and 2.64 (1.54-4.51) in women. Adjusting for other risk factors in addition, the HR was 1.54 (1.16-2.03) in men and 2.66 (1.45-4.90) in women. For 2-h insulin these HRs were 1.28 (0.99-1.66), 1.87 (0.87-4.02), and 0.85 (0.60-1.21), 1.36 (0.53-3.45). The overall HRs for interquartile ranges for fasting and 2-h insulin, with full adjustment, were 1.13 (1.05-1.22) and 1.11 (1.01-1.23) in men, and 1.25 (1.08-1.45) and 1.11 (0.91-1.36) in women. Hyperinsulinaemia, defined by the highest quartile cu...Continue Reading

References

Jul 1, 1991·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·M LaaksoP Karhapää
Jun 1, 1990·Diabetes Care·R W Stout
Jan 1, 1993·Statistical Methods in Medical Research·J L Fleiss
May 1, 1993·American Journal of Epidemiology·M Laakso
Apr 11, 1996·The New England Journal of Medicine·J P DesprésP J Lupien
Aug 1, 1996·American Journal of Epidemiology·I J PerryK G Alberti
Apr 1, 1997·Journal of the American Geriatrics Society·O LindbergJ Tuomilehto
Aug 15, 1997·American Journal of Epidemiology·L MykkänenM Laakso
Apr 7, 1998·Circulation·J B RuigeL M Bouter
Aug 26, 1998·The Journal of Clinical Endocrinology and Metabolism·J YipG M Reaven
Jan 27, 1999·Epidemiologic Reviews·A D LieseS M Haffner
May 26, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·B Balkau, M A Charles
Sep 14, 1999·Metabolism: Clinical and Experimental·B LindahlG Hallmans
Feb 15, 2001·Archives of Internal Medicine·UNKNOWN DECODE Study Group, the European Diabetes Epidemiology Group.
Apr 6, 2001·Diabetes Care·K A McAuleyA W Duncan
Jun 13, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·B HedbladL Janzon

❮ Previous
Next ❯

Citations

Oct 12, 2012·Diabetologia·K A M Jandeleit-Dahm, S P Gray
May 29, 2012·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·L M VoeghtlyD L Ellsworth
Jan 13, 2011·European Heart Journal·Genevieve N HealyNeville Owen
Feb 26, 2010·Diabetology & Metabolic Syndrome·Marcello C BertoluciBeatriz D Schaan
Jan 18, 2013·PloS One·Angela SciacquaGiorgio Sesti
Nov 9, 2011·Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association·Elif YorulmazIlyas Tuncer
Aug 8, 2014·Aesthetic Plastic Surgery·Filippo BorianiPaolo Giovanni Morselli
Dec 20, 2015·European Journal of Clinical Investigation·Laura Sánchez-ÍñigoJ A Martinez
Feb 6, 2009·Journal of Affective Disorders·Hui Hua ChangRu Band Lu
Oct 3, 2008·Atherosclerosis·Leendert H OterdoomStephan J L Bakker
May 21, 2014·Journal of Diabetes Investigation·Jeong-Ah ShinHo-Young Son
Jun 30, 2010·Fundamental & Clinical Pharmacology·Mariaelena LombardiGiuseppe M C Rosano
Jun 22, 2014·American Journal of Preventive Medicine·Miguel MarinoOrfeu M Buxton
May 6, 2014·International Journal of Cardiology·Simona I ChisalitaUrban Alehagen
Jul 25, 2013·Atherosclerosis·Maria A MariniGiorgio Sesti
Feb 12, 2017·Canadian Journal of Physiology and Pharmacology·Nathalia BernardesPawan K Singal
May 18, 2007·The New England Journal of Medicine·Petteri HoviEero Kajantie
Jun 1, 2014·European Journal of Preventive Cardiology·Margareta I HellgrenCharlotte A Larsson
Apr 29, 2009·Angiology·Necati DagliIbrahim H Bahcecioglu
Nov 1, 2006·Women's Health·Giuseppe Mc RosanoGiuseppe Mercuro
Nov 4, 2017·Medical Sciences : Open Access Journal·Lamiaa A A BarakatEl-Sayed Abd El-Sameeh El-Sayed
Apr 29, 2005·Diabetes/metabolism Research and Reviews
May 27, 2011·Journal of Medicinal Food·Joaquín Pérez-Guisado, Andrés Muñoz-Serrano
Jul 24, 2012·Metabolic Syndrome and Related Disorders·Vanessa PanzFrederick Raal
Mar 4, 2017·Circulation Research·Mauro Siragusa, Beate Fisslthaler
Jun 7, 2006·Current Opinion in Cardiology·Agnieszka Behn, Ehud Ur
Dec 22, 2006·European Journal of Clinical Investigation·A M J WassinkF L J Visseren

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.